'F--- the feds': Martin Shkreli barred from running all public companies as judge decries remorseless behavior
The court losses continue piling up for ex-”Pharma Bro” Martin Shkreli.
In a civil suit brought on by the SEC back in 2015, a US district judge in New York ruled Wednesday that Shkreli will be permanently barred from holding an officer or director role at any public company. The ban goes further than a federal judge’s ruling last month, which only barred Shkreli from running pharmaceutical companies.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 153,800+ biopharma pros reading Endpoints daily — and it's free.